Elevated Resting Heart Rate in Hospitalized Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk
Cardiovascular Therapeutics · 2026
DOI: 10.1155/cdr/2106637 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Cardiovascular Therapeutics, 2026. Verfasst von Kangning Han und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing, China, anzhen.org. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure, Heart Rate, Hospitalization. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project.
Abstract (Originalsprache)
Background
Effective rate control is important in the management of atrial fibrillation (AF). However, the relationship between resting heart rate (RHR) and adverse outcomes in hospitalized patients remains uncertain.
Objective
This study was to evaluate the association between RHR and in‐hospital outcomes.
Methods
Data from the Improving Care for Cardiovascular Disease in China‐AF project from 2014 to 2019 were retrospectively analyzed. The primary outcome was the composite of in‐hospital all‐cause mortality and in‐hospital acute heart failure (AHF). Secondary outcomes included stroke/transient ischemic attack (TIA) and bleeding during hospitalization. Logistic regression analyses were used to assess the association between RHR and outcomes.
Results
Our study included 12,775 patients hospitalized for AF in 236 hospitals. Logistic regression analyses using different models showed a significant association between RHR exceeding 80 bpm and an increased risk of the primary outcome (adjusted OR: 1.79 [95% CI: 1.44–2.22]). A positive association between RHR and the primary outcome was identified with RHR ≥ 80 bpm. Marginal effect analyses showed that patients with advanced AF types were at higher risk across the range of RHR. Conversely, catheter ablation, but not antiarrhythmic drug use, was associated with a decreased risk.
Conclusion
A significant association was identified between RHR and adverse outcomes in patients hospitalized for AF, where RHR exceeding 80 bpm was associated with an increased risk. Trial Registration: ClinicalTrials.gov identifier: NCT02309398
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing, China, anzhen.org.
- Department of Mathematical and Physical Sciences, La Trobe University, Melbourne, Australia, latrobe.edu.au.
- Department of Epidemiology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing, China, anzhen.org.
ORCID-Profile: Kangning Han, Xia Li, Biao Fu, Tong Liu, Ying Peng, Na Yang, Yongchen Hao, Jianzeng Dong, Deyong Long, Changsheng Ma
Förderung
- National Natural Science Foundation of China
- National Science and Technology Major Project
Zitieren
APA
Han, K., Li, X., Fu, B., Li, M., Liu, T., Peng, Y., Liu, J., Yang, N., Hao, Y., Jiang, C., Tang, R., Dong, J., Zhao, D., Long, D., & Ma, C. (2026). Elevated Resting Heart Rate in Hospitalized Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/2106637
Vancouver
Han K, Li X, Fu B, Li M, Liu T, Peng Y, et al. Elevated Resting Heart Rate in Hospitalized Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk. Cardiovascular Therapeutics. 2026. doi:10.1155/cdr/2106637
BibTeX
@article{Han2026,
author = {Han, Kangning and Li, Xia and Fu, Biao and Li, Mengmeng and Liu, Tong and Peng, Ying and Liu, Jing and Yang, Na and Hao, Yongchen and Jiang, Chenxi and Tang, Ribo and Dong, Jianzeng and Zhao, Dong and Long, Deyong and Ma, Changsheng},
title = {Elevated Resting Heart Rate in Hospitalized Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk},
journal = {Cardiovascular Therapeutics},
year = {2026},
doi = {10.1155/cdr/2106637}
}
EUVIMED